Hint mode is switched on Switch off
For swift navigation between sections

International bonds: Teva Pharmaceutical Industries, 4.5% 1mar2025, EUR
XS1789456024

Download
Copy issue information to clipboard
Copy issue information to clipboard
Copy

Issue
Issuer
  • M
    -
    ***
  • S&P
    -
    ***
  • F
    -
    ***
Status
Outstanding
Amount
2,200,000 EUR
Placement
***
Early redemption
*** (-)
Country of risk
Israel
Current coupon
***%
Price
***%
Yield / Duration
-
Corporate Actions Issuer news
Add issue to Watchlist
{{ watchlistErrorMsg }}
Adding issue to the Watchlist is not possible because there are no quotes from exchanges for it.
DATA PLATFORM FOR FINANCIAL MARKET PROFESSIONALS AND INVESTORS
  • High performance interface for global bond market screening
  • Full information on close to 400,000 bonds from 180 countries
  • 100% coverage of Eurobonds worldwide
  • Over 300 primary sources of prices
  • Ratings data from all international and local ratings agencies
  • Stock market data from 60 world trading floors
  • Intuitive, high speed user interface
  • Data access via the website, mobile application and add-in for Microsoft Excel

Trading chart

Stock exchange selection
Stock exchange selection
More about Cbonds Estimation
Data display in a chart | table
Data display in a chart | table
Work with the chart: switching the price, period, issue comparison
Work with the chart: switching the price, period, issue comparison
Download the chart in a convenient format
More than 2,500 records have been found, please specify your request
* Data is not available within the selected subscription
Latest data on
Quotes from market participants are indicative

Stock exchange and OTC quotes

Issue information

Profile
Teva Pharmaceutical Industries Ltd., is a global pharmaceutical company. The Company develops, manufactures, and markets generic and branded human pharmaceuticals as well as active pharmaceutical ingredients.
Volume
  • Amount
    900,000,000 EUR
  • Outstanding amount
    2,200,000 EUR
  • Outstanding face value amount
    2,200,000 EUR
  • USD equivalent
    2,567,180 USD
Nominal
  • Minimum Settlement Amount
    100,000 EUR
  • Outstanding face value
    *** EUR
  • Par amount, integral multiple
    *** EUR
  • Nominal
    1,000 EUR

Cash flow parameters

  • Reference rate
    ***
  • Coupon Rate
    ***
  • Day count fraction
    ***
  • Business Day Convention
    Following Business Day
  • Interest Accrual Date
    ***
  • Coupon frequency
    *** time(s) per year
  • Payment currency
    ***
  • Delay days
    *** days
  • Maturity date
    ***
  • Early redemption date
    ***

Cash flow

Calculations for international bonds are made according to the minimum trading lot

Early redemption terms

***

DATA PLATFORM FOR FINANCIAL MARKET PROFESSIONALS AND INVESTORS
  • High performance interface for global bond market screening
  • Full information on close to 400,000 bonds from 180 countries
  • 100% coverage of Eurobonds worldwide
  • Over 300 primary sources of prices
  • Ratings data from all international and local ratings agencies
  • Stock market data from 60 world trading floors
  • Intuitive, high speed user interface
  • Data access via the website, mobile application and add-in for Microsoft Excel

Placement

  • Placement method
    Open subscription
  • Placement type
    Public
  • Order book
    *** (***) - *** (***)
  • Coupon (Yield) Guidance
    ***% - ***% (*** - ***%)
  • Issuer rating on issue date (M/S&P/F)
    *** / *** / ***
  • Placement
    *** - ***
  • Initial issue price (yield)
    (***%)
  • Bids
    *** EUR
  • Number of bids
    ***
  • Geographic breakdown
    ***
  • Investor breakdown
    ***
  • The purpose of placing
    We expect that the net proceeds to us from this offering and the concurrent offering, after deducting the Initial Purchasers’ discounts and estimated offering expenses payable by us, will be approximately $4,465 million. We expect to use the net proceeds of this offering, together with the net proceeds from the concurrent offering, to repay outstanding indebtedness, including indebtedness under the Term Loan Credit Agreement, dated as of November 16, 2015 (the “USD Term Loan Credit Agreement”), the Senior Unsecured Fixed Rate Japanese Yen Term Loan Credit Agreement, dated as of March 28, 2012 (the “JPY 2012 Credit Agreement”), the Senior Unsecured Japanese Yen Term Loan Credit Agreement, dated as of December 17, 2013 (the “JPY 2013 Credit Agreement”) and the Senior Unsecured Japanese Yen Term Loan Credit Agreement, dated as of March 22, 2017 (the “JPY 2017 Credit Agreement” and, collectively with the USD Term Loan Credit Agreement, the JPY 2012 Credit Agreement and the JPY 2013 Credit Agreement, in each case, as amended, the “Term Loan Credit Agreements”), the 1.40% USD Senior Notes due 2018 and the 2.875% EUR Senior Notes due 2019 with the remainder of the net proceeds to be used to pay related fees and expenses and/or otherwise for general corporate purposes.
  • Listing
    ***
Participants
  • Bookrunner
    ***, ***, ***, ***, ***, ***
  • Depository
    ***, ***
  • Issuer Legal Adviser (International law)
    ***
  • Paying agent
    ***

Conversion and exchange

Additional information

***

Latest issues

Stocks

Identifiers

  • Registration
    ***
  • Date of program registration
    ***
  • ISIN RegS
    XS1789456024
  • ISIN 144A
    XS1789459473
  • CUSIP RegS
    ***
  • CUSIP 144A
    ***
  • Common Code RegS
    178945602
  • Common Code 144A
    178945947
  • CFI RegS
    DBFUFR
  • CFI 144A
    DBFUFR
  • FIGI RegS
    BBG00K6R14Q1
  • FIGI 144A
    BBG00K6R0Q10
  • WKN RegS
    A19XUC
  • WKN 144A
    A19XUD
  • SEDOL
    BF4JDC0
  • Ticker
    TEVA 4.5 03/01/25 REGS
  • Type of security by CBR
    ***

Ratings

Issue ratings
Issuer ratings

Bond classification

  • Registered
  • Coupon bonds
  • Amortization
  • CDO
  • Convertible
  • Dual currency bonds
  • For qualified investors
  • Foreign bonds
  • Green bonds
  • Indexed
  • Supranational bond issues
  • Mortgage bonds
  • Perpetual
  • Payment-in-kind
  • Non-Marketable Securities
  • Redemption Linked
  • Restructuring
  • Retail bonds
  • Covered
  • Securitization
  • Structured product
  • Subordinated
  • Sukuk
  • Trace-eligible

Restructuring

***

***